Literature DB >> 6957261

Sensitivity of cultured human osteosarcoma and chondrosarcoma cells to retinoic acid.

R Thein, R Lotan.   

Abstract

The ability of retinoic acid (RA) to inhibit the growth of three cell lines (Te85, Hs781, and Hs791) derived from human osteosarcomas and two cell lines (Hs705 and Hs819) derived from human chondrosarcomas was studied in culture. The exposure to 10(-5) M RA resulted, within 4 days, in changes in both cell morphology and cell growth. RA-treated cells appeared flat and spread on the substratum more than untreated cells, their exponential growth rates decreased, and their saturation densities were markedly reduced. All these effects could be reversed by removal of RA from the growth medium. The various cell lines exhibited differential susceptibility to the growth-inhibitory effect of RA. The most sensitive was the Hs705 chondrosarcoma. The proliferation of these cells was inhibited 50% by 10(-9) M RA and was completely blocked by 10(-5) m RA. In contrast, the concentrations of RA required for 50% inhibition of Hs791, Te85, Hs819, and Hs781 were 10(-7), 2 X 10(-7), 2.5 X 10(-7), and 2 X 10(-6) M, respectively. Only the Te85 and the Hs781 osteosarcoma cells and cells derived from a chondrosarcoma biopsy were able to form colonies in a semisolid medium, and this growth was dramatically inhibited by RA. These results demonstrate that RA can suppress in these mesenchymal tumor cells the expression of morphological and growth properties frequently associated with transformed cells.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6957261

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  12 in total

1.  Specific down-regulation of parathyroid hormone (PTH) receptors and responses to PTH by tumour necrosis factor alpha and retinoic acid in UMR 106-06 osteoblast-like osteosarcoma cells.

Authors:  H G Schneider; E H Allan; J M Moseley; T J Martin; D M Findlay
Journal:  Biochem J       Date:  1991-12-01       Impact factor: 3.857

2.  Selective Agonists of Nuclear Retinoic Acid Receptor Gamma Inhibit Growth of HCS-2/8 Chondrosarcoma Cells.

Authors:  William P Shield; Ashley Cellini; Hongying Tian; Kim Wilson; Yang Dan; Joshua M Abzug; Sonia Garcia; Norifumi Moritani; Ivan Alferiev; Michael Chorny; Masaharu Takigawa; Vincent Y Ng; Masahiro Iwamoto; Motomi Enomoto-Iwamoto
Journal:  J Orthop Res       Date:  2019-12-19       Impact factor: 3.494

3.  Phase I study of tamibarotene monotherapy in pediatric and young adult patients with recurrent/refractory solid tumors.

Authors:  Chika Nitani; Junichi Hara; Hiroshi Kawamoto; Tomoaki Taguchi; Toshimi Kimura; Kenichi Yoshimura; Akinobu Hamada; Shigehisa Kitano; Naoko Hattori; Toshikazu Ushijima; Hiromi Ono; Masako Nakamoto; Tsukiko Higuchi; Akihiro Sato
Journal:  Cancer Chemother Pharmacol       Date:  2021-04-07       Impact factor: 3.333

Review 4.  Neuronal differentiation of synovial sarcoma and its therapeutic application.

Authors:  Tatsuya Ishibe; Tomitaka Nakayama; Tomoki Aoyama; Takashi Nakamura; Junya Toguchida
Journal:  Clin Orthop Relat Res       Date:  2008-06-19       Impact factor: 4.176

5.  A phase 1 and pharmacokinetic study using the aromatic retinoic acid analogue dichloroetretinate (Ro 12-7554).

Authors:  B A Zonnenberg; A von Dijk; C P Vendrik; J H Schornagel; A Struyvenberg
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

6.  A novel retinoic acid-response element requires an enhancer element mediator for transcriptional activation.

Authors:  Laura R Harris; Olli-Pekka Kamarainen; Minna Sevakivi; Gwen C Miller; James W Clarke; Jennifer L Potter; Laura C Bridgewater
Journal:  Biochem J       Date:  2004-10-01       Impact factor: 3.857

7.  Vitamin A effects on UMR 106 osteosarcoma cells are not mediated by specific cytosolic receptors.

Authors:  R O Oreffo; J A Francis; J T Triffitt
Journal:  Biochem J       Date:  1985-12-01       Impact factor: 3.857

Review 8.  Retinoic acid actions through mammalian nuclear receptors.

Authors:  Pengxiang Huang; Vikas Chandra; Fraydoon Rastinejad
Journal:  Chem Rev       Date:  2013-12-05       Impact factor: 60.622

Review 9.  Solid tumor differentiation therapy - is it possible?

Authors:  Filemon Dela Cruz; Igor Matushansky
Journal:  Oncotarget       Date:  2012-05

10.  Characterization of a new human osteosarcoma cell line OHS-4.

Authors:  B Fournier; P A Price
Journal:  J Cell Biol       Date:  1991-08       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.